PROCEEDINGS VOLUME 10861
SPIE BIOS | 2-7 FEBRUARY 2019
Mechanisms of Photobiomodulation Therapy XIV
IN THIS VOLUME

6 Sessions, 13 Papers, 12 Presentations
Proceedings Volume 10861 is from: Logo
SPIE BIOS
2-7 February 2019
San Francisco, California, United States
PBM Mechanisms I
Proc. SPIE 10861, Transcranial infrared laser stimulation enhances cross-frequency phase-amplitude coupling of brain oscillations in vivo measured by electroencephalography (Conference Presentation), 1086103 (4 March 2019); doi: 10.1117/12.2510882
Proc. SPIE 10861, Validation of a Monte Carlo modeling based dosimetry of extraoral photobiomodulation (Conference Presentation), 1086104 (13 March 2019); doi: 10.1117/12.2510986
Proc. SPIE 10861, Intra-spinal irradiation distribution associated with local light delivery as measured in a pilot rabbit model: Implications toward epidural photo-neuro-modulation of the spinal cord (Conference Presentation), 1086105 (4 March 2019); doi: 10.1117/12.2506651
PBM Mechanisms II
Proc. SPIE 10861, Photon absorption in the mitochondria: Potential immediate and early events associated with photobiomodulation, 1086106 (7 March 2019); doi: 10.1117/12.2508518
Proc. SPIE 10861, Blue light effects in human keloid fibroblasts, 1086107 (7 March 2019); doi: 10.1117/12.2509504
Proc. SPIE 10861, Quantification of hemodynamic and metabolic effects of wavelength-dependent photobiomodulation measured by broadband near infrared spectroscopy on human forearms (Conference Presentation), 1086108 (4 March 2019); doi: 10.1117/12.2510865
PBM Mechanisms III
Proc. SPIE 10861, Potentials of noninvasive low-level laser therapy for neonatal thrombocytopenia, 1086109 (7 March 2019); doi: 10.1117/12.2507053
Proc. SPIE 10861, Reactive oxygen species explicit dosimetry to predict tumor growth for BPD-mediated vascular photodynamic therapy, 108610A (7 March 2019); doi: 10.1117/12.2514657
PBM Innovation and Commercialization
Proc. SPIE 10861, Fat loss by red and near infrared LED phototherapy, 108610B (7 March 2019); doi: 10.1117/12.2506800
Proc. SPIE 10861, Novel technology platform for PBM delivery using printed LEDs, 108610D (7 March 2019); doi: 10.1117/12.2508729
Proc. SPIE 10861, Investigation of reaction mechanisms of cytochrome c and mitochondria with transient absorption spectroscopy, 108610E (7 March 2019); doi: 10.1117/12.2508170
New Investigator
Proc. SPIE 10861, A fluorescence-based approach to probing the immediate/early molecular mechanisms of photobiomodulation in vitro, 108610F (7 March 2019); doi: 10.1117/12.2508961
Proc. SPIE 10861, In vivo quantification of nitric oxide (NO) release from intact human skin following exposure to photobiomodulation wavelengths in the visible and near infrared spectrum, 108610G (7 March 2019); doi: 10.1117/12.2508707
Proc. SPIE 10861, Proposal and justification of a treatment protocol for extraoral photobiomodulation therapy for the prevention of oral mucositis (Conference Presentation), 108610H (13 March 2019); doi: 10.1117/12.2511007
Proc. SPIE 10861, Measuring cytochrome c redox state using resonance Raman spectroscopy to determine metabolic rates in electron transport chain when exposed to light, 108610I (7 March 2019); doi: 10.1117/12.2508684
Proc. SPIE 10861, Effects of probe parameters on photobiomdulation therapy for spinal cord injury: a numerical algorithm modelling study, 108610J (7 March 2019); doi: 10.1117/12.2508719
PBM Clinical Translation
Proc. SPIE 10861, The effects of a wearable pulsed blue-red light patch on muscle recovery and fatigue (Conference Presentation), 108610K (13 March 2019); doi: 10.1117/12.2508513
Proc. SPIE 10861, Effects of high and low level 1265 nm laser irradiation on HCT116 cancer cells, 108610L (7 March 2019); doi: 10.1117/12.2509529
Proc. SPIE 10861, What is the prospect of transcutaneous transmission of 980nm photobiomodulation therapy light to the spinal canal?, 108610N (7 March 2019); doi: 10.1117/12.2506435
Back to Top